Changes in psychic and somatic well-being and cognitive capabilities of peri- and postmenopausal women after the use of a hormone replacement drug containing estradiol valerate and levonorgestrel

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 22, Issue 1, 2000, Pages 51-56

  Rudolph, I ^a   Zimmermann, T ^a   Kaminski, K ^b   Jandova, K ^c   Borovsky, B ^c   Ahrendt, H J ^d   Golbs, S ^a  

^a BAYER PHARMA AG   (Germany)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c I Clin of Gynaecol and Obstetrics   (Slovakia)

^d Praxis im Augusta Bad   (Germany)

Author keywords

Climatic syndrome; Cognitive capabilities; Hormone replacement therapy; Klimonorm ; Menopausal women; Psychic and somatic well being

Indexed keywords

ESTRADIOL VALERATE; ESTRADIOL VALERATE PLUS NORGESTREL; LEVONORGESTREL;

ADULT; AGED; ARTICLE; CLIMACTERIUM; COGNITION; DRUG EFFECT; EMOTIONAL STABILITY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; RATING SCALE; SELF ESTEEM; WELLBEING;

EID: 0034066748     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2000.22.1.795841     Document Type: Article

References (21)

1. Hönigl, D., Mahnert, F., Zapotoczky, H.G. Neuroendokrine veränderungen im klimakterium. In: Menopause: Die Hormon-substitution im Wandel der Zeit. Neueste Erkenntnisse und Therapiekonzepte. Fischl, F.H., Huber, J.C. (Eds.). Krause & Pachernegg GmbH, Verlag für Medizin und Wirtschaft: Wien 1995, 107-15.
2. Goldani von Muhlen, D., Kritz-Silverstein, D., Barret-Connor, E. A community-based study of menopause symptoms and estrogen replacement in older women. Maturitas 1995, 22: 71-8.
3. Stadberg, E., Mattsson, L.A., Milsom, I. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population. Acta Obstet Gynecol Scand 1997, 76(5): 442-8.
4. Janowsky, D.S., Halbreich, U., Rausch, J. Associations among ovarian hormones, other hormones, emotional disorders and neurotransmitters. In: Psychopharmacology and Women. Jensvold M.F., Halbreich, U., Hamilton, J.A. (Eds.). American Psychiatric Press: Washington 1996.
5. Hauser, G.H. Neue Bewertungskala für das klimakterische Syndrom (Menopause Rating Scale [MRS]. Schweiz Med Wochenschr 1997, 127: 122-7.
6. Hautzinger, M., Bailer, M. Allgemeine Depressions Scala, ADS. Beltz Verlag: Weinheim 1993.
7. Halbreich, U. Role of estrogen in postmenopausal depression. Neurology 1997, 48(Suppl 7): S16-9.
8. Brace, M., McCauley, E. Oestrogens and psychological well-being. Ann Med 1997, 29: 283-90.
9. Sherwin, B. Hormones, mood and cognitive functioning in post-menopausal women. Obstet Gynaecol 1996, 87(2): 20-6.
10. Zweifel, J.E., O'Brien, W.H. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997, 22(3): 189-212.
11. Chakravarti, S., Collins, W.P., Thom, M.H., Studd, J.W.W. Relation between plasma hormone profiles, symptoms and response to oestrogen treatment in women approaching the menopause. Br Med J 1979, 279(1): 983-5.
12. Wieck, A. Ovarian hormones, mood and neurotransmitters. Int Rev Psych 1996, 8: 17-25.
13. Ross, L.A., Alder, E.M., Brown, J., Cawood, E.H.H., Gebbie, A.E. Psychological effects of hormone repalcement therapy: A comparison of tibolone and conjugated oestrogens. 1997 (unpublished data).
14. Dennerstein, L., Dudley, E., Burger H. Well-being and the menopausal transition. J Psychosom Obstet Gynaecol 1997, 18: 95-101.
15. Foremanek, R. Depression and menopause: A socially constructed link. In: Women and Depression: A Lifespan Perspective. Springer Series: Focus on Women, vol. 11. Foremanek, R., Gurian, A. (Eds.). Springer Publishing Co.: New York 1987, 255-71.
16. Kuhl, H. Taubert, H.D. Das Klimakterium: Pathophysiologie, Klinik, Therapie. Georg Thieme Verlag: Stuttgart, New York 1987.
17. Wenderlein, J. M. Hormonal contraceptives cause depression? Med Klin 1981, 76: 288-90.
18. Banger, M., Rimpel, J., Feldmann, H.U. Zentralnervöse und pharmako-EEG-effekte von östradiol: Eine peri-/postmenopausale hormonsubstitution hat auch viel-fältige psychotrope wirkungen. Gyne 1995, 12: 253-7.
19. Haskell, S.G., Richardson, E.D., Harwitz, R.I. The effect of estrogen replacement therapy on cognitive function in women. A critical review of the literature: J Clin Epidemiol 1997, 50: 1249-64.
20. Wolf, A.S. Neuronen, synapsen, neurotransmitter: Wirkungen der sexualsteroide' im zentralnervensystem der fran. Gynäko-Endokrinol 1995, 3: 15-23.
21. Fink, G., Sumner, B.K., Rosie, R., Grace, O., Quinn, J.P. Estrogen control of central neurotransmission: Effect on mood, mental state, and memeory. Cell Mol Neurobiol 1996, 16(3): 325-44.